- Home
- ORIC vs HUMA Comparison
ORIC vs HUMA Comparison
Compare ORIC & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- HUMA
- Stock Information
- Founded
- ORIC 2014
- HUMA 2004
- Country
- ORIC United States
- HUMA United States
- Employees
- ORIC N/A
- HUMA N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- ORIC Health Care
- HUMA Health Care
- Exchange
- ORIC Nasdaq
- HUMA Nasdaq
- Market Cap
- ORIC 735.3M
- HUMA 584.8M
- IPO Year
- ORIC 2020
- HUMA N/A
- Fundamental
- Price
- ORIC $10.84
- HUMA $4.37
- Analyst Decision
- ORIC Strong Buy
- HUMA Strong Buy
- Analyst Count
- ORIC 9
- HUMA 7
- Target Price
- ORIC $18.75
- HUMA $13.43
- AVG Volume (30 Days)
- ORIC 825.1K
- HUMA 2.4M
- Earning Date
- ORIC 03-10-2025
- HUMA 03-21-2025
- Dividend Yield
- ORIC N/A
- HUMA N/A
- EPS Growth
- ORIC N/A
- HUMA N/A
- EPS
- ORIC N/A
- HUMA N/A
- Revenue
- ORIC N/A
- HUMA N/A
- Revenue This Year
- ORIC N/A
- HUMA N/A
- Revenue Next Year
- ORIC N/A
- HUMA $4,344.68
- P/E Ratio
- ORIC N/A
- HUMA N/A
- Revenue Growth
- ORIC N/A
- HUMA N/A
- 52 Week Low
- ORIC $6.33
- HUMA $2.81
- 52 Week High
- ORIC $16.65
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- ORIC 52.90
- HUMA 45.11
- Support Level
- ORIC $9.92
- HUMA $4.20
- Resistance Level
- ORIC $12.00
- HUMA $4.78
- Average True Range (ATR)
- ORIC 0.90
- HUMA 0.28
- MACD
- ORIC 0.04
- HUMA -0.02
- Stochastic Oscillator
- ORIC 41.82
- HUMA 42.17
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.